White matter injury in the preterm infant: An important determination of abnormal neurodevelopment outcome

Early Human Development

Volumn 53, Issue 2, 1998, Pages 99-120

  Perlman, Jeffrey M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Outcome; Pathogenesis; Periventricular intraventricular hemorrhage; Periventricular Leukomalacia; Prevention

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; CYTOKINE; ETAMSYLATE; FREE RADICAL; GLUCOCORTICOID; INDOMETACIN; PHENOBARBITAL; VITAMIN K GROUP;

BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; CHORIOAMNIONITIS; COGNITION; ENCEPHALOMALACIA; FETUS HYPOXIA; HUMAN; HYPOCAPNIA; HYPOTENSION; LOW BIRTH WEIGHT; MOTOR PERFORMANCE; NERVOUS SYSTEM MALFORMATION; NEUROTOXICITY; NEWBORN; NEWBORN MORTALITY; OLIGODENDROGLIA; PATHOGENESIS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; REVIEW; SEPSIS; VISION; WHITE MATTER;

EID: 0032404075     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(98)00037-1     Document Type: Article

References (134)

1. Perlman J.M., Rollins N., Burns D., Risser R. Relationship between periventricular intraparenchymal echodensities and germinal matrix-intraventricular hemorrhage in the very low birth weight neonate. Pediatrics. 91:1993;474-480.
2. Perlman J.M., Risser R., Broyles R.S. Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics. 97:1996;822-827.
3. Volpe JJ. Neurology of the newborn. third edition. Philadelphia, PA: Saunders, 1995:294-99.
4. Leviton A., Paneth N. White matter damage in preterm newborns - an epidemiologic perspective. Early Hum Dev. 24:1990;1-22.
5. De Vries L.S., Regev R., Dubowitz L.M.S., Whitelaw A.et al. Perinatal risk factors for the development of extensive cystic leukomalacia. Am J Dis Child. 142:1988;732-735.
6. De Vries L.S., Regev R., Dubowitz L.M.S. Late onset cystic leukomalacia. Arch Dis Child. 61:1986;298-299.
7. Banker B.Q., Larroche J.C. Periventricular leukomalacia of infancy: a form of neonatal anoxic encephalopathy. Arch Neurol. 7:1962;386-410.
8. De Reuck J., Chatta A.S., Richardson E.P. Jr. Pathogenesis and evolution of periventricular leukomalacia in infancy. Arch Neurol. 27:1972;229-236.
9. Armstrong D., Norman M.G. Periventricular leukomalacia in neonates: complications and sequelae. Arch Dis Child. 49:1974;367-375.
10. Paneth N., Rudelli R., Monte W., Rodriguez E.et al. White matter necrosis in the very low birth weight infants: neuropathologic and ultrasonographic findings in infants surviving six days or longer. J Pediatr. 116:1990;975-984.
11. Takashima S., Becker L.E., Tanaka J. Developmental changes of glial acidic fibrillary protein and myelin basic protein in perinatal leukomalacia: relationship to predisposing factors. Brain Dev. 6:1984;444-450.
12. De Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol. 5:1971;321-334.
13. Takashima S., Tanaka K. Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol. 35:1978;11-16.
14. De Reuck J. Cerebral angioarchitecture and perinatal brain lesions in premature and full term infants. Acta Neurol Scand. 70:1984;391-395.
15. Rorke L.B. Anatomic features of the developing brain implicated to hypoxic-ischemic injury. Brain Pathol. 2:1992;211-221.
16. Larroche JC. Developmental pathology of the neonate. New York: Raven Press, 1977.
17. Cavazzutti M., Duffy T.E. Regulation of local cerebral blood flow in normal and hypoxic newborn dogs. Ann Neurol. 11:1982;247-257.
18. Szymonowicz W., Walker A.M., Yu Y.H., Cannata J.et al. Regional cerebral blood flow after hemorrhagic hypotension in the preterm, near term and term lamb. Pediatr Res. 28:1990;361-370.
19. Young R.S.K., Hernandez M.J., Yagel S.K. Selective reduction of blood flow to white matter during hypotension in newborn dogs: a possible mechanism of periventricular leukomalacia. Ann Neurol. 12:1982;445-448.
20. Lou C.H., Lassen N.A., Friis-Hansen B. Impaired autoregulation of cerebral blood flow in the distressed newborn infant. J Pediatr. 94:1979;118-125.
21. Pryds O., Griesen G., Lou H., Friis-Hansen B. Heterogeneity of cerebral vasoreactivity in preterm infants supported by mechanical ventilation. J Pediatr. 115:1989;638-645.
22. Low J.A., Froese A.F., Galbraith R.S.et al. The association of fetal and newborn acidosis with severe periventricular leukomalacia in the preterm infant. Am J Obstet Gynecol. 162:1990;977-982.
23. Faix R.G., Donn S.M. Association of septic shock caused by early onset Group B streptococcal sepsis and periventricular leukomalacia in the preterm infant. Pediatrics. 76:1985;415-419.
24. Miall-Allen V.M., De Vries L.S., Whitelaw A.G. Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child. 62:1987;1068-1069.
25. Greisen G., Munck H., Lou H. Severe hypocarbia in preterm infants and neurodevelopmental deficit. Acta Paediatr Scand. 76:1986;401-404.
26. Fujimoto S., Togari H., Yamaguchi N.et al. Hypocarbia and cystic periventricular leukomalacia in premature infants. Arch Dis Child. 71:1994;F107-F110.
27. Wiswell T.E., Graziani L.J., Kornhauser M.S. Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high frequency jet ventilation. Pediatrics. 98:1996;918-924.
28. Perlman J.M., Hill A., Volpe J.J. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr. 99:1981;767-771.
29. Perlman J.M., Volpe J.J. Episodes of apnea and bradycardia in the preterm newborn: impact on cerebral circulation. Pediatrics. 76:1985;333-338.
30. Rice J.E. III, Vannucci R.C., Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 9:1981;131-141.
31. Oka A., Belliveau M.J., Rosenberg P.A.et al. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms and prevention. J Neurosci. 13:1993;1331-1453.
32. Leviton A., Gilles F.H. Acquired perinatal leukoencephalopathy. Ann Neurol. 16:1984;1-8.
33. Adinolfi M. Infectious diseases in pregnancy, cytokines and neurologic impairment: a hypothesis. Dev Med Child Neurol. 35:1993;549-553.
34. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol. 35:1993;553-558.
35. Minami M., Kurashi Y., Yabuuchi K.et al. Induction of interleukin 1β mRNA in rat brain after transient forebrain ischemia. J Neurochem. 58:1992;390-392.
36. Merrill J.E., Koyanagi Y., Zack J.et al. Induction of interleukin-I and tumor necrosis factor alpha in brain cultures by human immuno-deficiency virus type 1. J Virol. 66:1992;2217-2225.
37. Hillier S.L., Witkin S.S., Krohn M.A., Wahs D.H.et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis and chorioamnion infection. Obstet Gynecol. 174:1996;330-334.
38. Saito S., Kasahara T., Kato Y., Ishihara Y.et al. Elevation of amniotic fluid interleukin 6- (IL-6), IL-8, and granulocyte stimulating factor (G-CSF) in term and preterm parturition. Cytokines. 5:1993;81-88.
39. Zupman V., Gonzalez P., Lacaze-Masmontiel T., Bothias C.et al. Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol. 38:1996;1066-1067.
40. Gilles F.H., Leviton A., Kerr C.S. Endotoxin leukoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci. 27:1976;183-191.
41. Ornoy A., Altschulerg G. Maternal endotoxemia, fetal anomalies and central nervous system damage: a rat model of a human problem. Am J Obstet Gynecol. 124:1976;196-204.
42. Deguchi K., Mizoguchi M., Takashimas S. Immunohistochemical expression of tumor necrosis factor ∝ in neonatal leukomalacia. Pediatr Neurol. 14:1996;13-16.
43. Yoon B.H., Romero R., Kim C.J., Namkoo J.et al. High expression of tumor necrosis factor ∝ and interleukin 6 in periventricular leukomalacia. Am J Obstet Gynecol. 177:1997;406-411.
44. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H.et al. Interleukin-I as a pathogenic mediator of ischemic brain damage in rats. Stroke. 26:1995;676-681.
45. Relton J.K., Rothwell N.J. Interleukin-I receptor antagonism inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res Bull. 29:1992;243-246.
46. Nestlin W.F., Gimbrone M.A. Jr. Neutrophil-mediated damage to human vascular endothelium: role of cytokine activation. Am J Pathol. 142:1993;117-128.
47. Kikuchi T., Okuda Y., Kaito N., Abe T. Cytokine production in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res. 17:1995;106-108.
48. Bruce A.J., Boling W., Kindy M.S., Peschon J.et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptor. Nat Med. 2:1996;788-794.
49. De Vries L.S., Connell J.A., Dubowitz L.M.S., Oozeer R.C.et al. Neurological, electrophysiological and MRI abnormalities in infants with extensive cystic leukomalacia. Neuropediatrics. 18:1987;61-66.
50. Bejar R., Wozniak P., Allard M., Benirschke K.et al. Antenatal origin of neurologic damage in newborn infants. I. Preterm infants. Am J Obstet Gynecol. 159:1988;357-363.
51. Gaffrey G., Squier M.V., Johnson A., Flavell V.et al. Clinical associations of prenatal ischemic white matter injury. Arch Dis Child. 70:1996;F101-106.
52. Perlman J.M., Argyle C. Lethal cytomegalovirus infection in preterm infants: clinical radiological and neuropathologic findings. Ann Neurol. 31:1992;64-68.
53. Dixon S.D., Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr. 115:1989;770-778.
54. Weindling A.M., Wilkinson A.R., Cook F., Calvert S.A.et al. Perinatal events which precede periventricular hemorrhage and leukomalacia in the newborn. Br J Obstet Gynecol. 92:1985;1218-1223.
55. Trounce J.Q., Shaw D.E., Levene M.I., Rutter N. Clinical risk factors and periventricular leukomalacia. Arch Dis Child. 63:1988;17-22.
56. Graziani L.J., Spitzer A.R., Mitchell D.G., Merron D.A.et al. Mechanical ventilation in preterm infants: neurosonographic and developmental studies. Pediatrics. 90:1992;515-522.
57. Grether J.K., Nelson K.D. Maternal infection and cerebral palsy in infants of normal birth weight. J Am Med Assoc. 278(3):1997;207-211.
58. Mirro R., Buslta D., Green R., Leffler C.B. Relationship between mean airway pressure, cardiac output and organ blood flow with normal and decreased respiratory compliance. J Pediatr. 111:1987;101-106.
59. Vert P, Monin P, Sibout M. Intracranial venous pressure in newborns: variations in physiologic and neurologic disorders. In: Stern L, Friis Hansen B, Kildeberg P, editors. Intensive care of newborn. New York: Masson, 1975:185.
60. Phelps D.L., Rosenbaum A.L., Isenberg S.J., Leake R.D.et al. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized controlled, double-masked trial. Pediatrics. 79:1987;489-500.
61. Fazzi E., Lanzi G., Gerardo A., Ometto A.et al. Neurodevelopmental outcome in very low birth weight infants with or without periventricular hemorrhage and/or leukomalacia. Acta Paediatr. 81:1992;808-811.
62. Roger B., Msall M., Owens T., Guernsey K.et al. Cystic periventricular leukomalacia and type of cerebral palsy in preterm infants. J Pediatr. 125:1994;51-58.
63. De Vries L.S., Eken P., Groenendaal F., Van Haastert I.C.et al. Correlation between the degree of periventricular leukomalacia using cranial ultrasound and MRI in infancy in children with cerebral palsy. Neuropediatrics. 24:1993;263-268.
64. Scher M.S., Dobson V., Carpenter N.A., Guthrie R.D. Visual and neurological outcome of infants with periventricular leukomalacia. Dev Med Child Neurol. 31:1989;353-365.
65. Evrard P., Gressens P., Volpe J.J. New concepts to understand the neurologic consequences of subcortical lesions in the premature brain. Biol Neonate. 61:1992;1-3.
66. Jongmans M., Henderson S., de Vries L., Dubowitz L. Duration of periventricular densities in preterm infants and neurological outcome at 6 years of age. Arch Dis Child. 69:1993;9-13.
67. Ringleberg J., Van der Bor M. Outcome of transient periventricular echodensities in preterm infants. Neuropediatrics. 24:1993;269-273.
68. Stewart A.L., Reynolds E.O.R., Hope R.L., Hamilton P.J.et al. Probability of neurodevelopmental disorders estimated from ultrasound appearance of brains of very preterm infants. Dev Med Child Neurol. 29:1987;3-11.
69. Dambska M., Laure-Kamionowska M., Schmidt-Sidor B. Early and late neuropathological changes in perinatal white matter damage. J Child Neurol. 4:1989;291-298.
70. De Vries L., Wiggelsworth J.S., Regev R., Dubowitz L.M. Evaluation of periventricular leukomalacia during the neonatal period and infancy: correlation of imaging and postmortem findings. Early Hum Dev. 17:1988;205-219.
71. Van der Bor M., den Ouden L., Guit G.L. Value of cranial ultrasound and magnetic resonance imaging in predicting neurodevelopmental outcome in preterm infants. Pediatrics. 90:1992;196-199.
72. Philips A.G.S., Allen W.C., Tito A.M., Wheeler L.R. Intraventricular hemorrhage in preterm infants: declining incidence in the 1980's. Pediatrics. 84:1989;797-800.
73. Fanaroff A.A., Wright L.L., Stevenson D.K.et al. Very low birthweight outcome of the NICHD Neonatal Research Network May 91 to Dec 92. Am J Obstet Gynecol. 173:1995;269-274.
74. Guzzetta F., Schackelford G.D., Volpe S., Perlman J.M.et al. Periventricular intraparenchymal echodensities in the premature newborn: critical determinant of neurologic outcome. Pediatrics. 78:1986;945-1006.
75. Gould S.J., Howard S., Hope P.L., Reynold E.O. Periventricular intraparenchymal cerebral hemorrhage in preterm infants: the role of venous infarction. J Pathol. 151:1987;197-202.
76. Goddard-Finegold J., Armstrong D., Zeller R.S. Intraventricular hemorrhage following volume expansion after hypovolemic hypotension in the newborn beagle. J Pediatr. 100:1982;796-799.
77. Ment L.R., Stewart W.B., Duncan C.C., Lambrecht R. Beagle puppy model of intraventricular hemorrhage. J Neurosurg. 57:1982;219-223.
78. Perlman J.M., McMenamin J.B., Volpe J.J. Fluctuating cerebral blood flow velocity in respiratory distress syndrome. Relation to the development of intraventricular hemorrhage. New Engl J Med. 309:1983;204-209.
79. Goldberg R.N., Chung D., Goldman S.L., Bancalari E. The associations of rapid volume expansion and intraventricular hemorrhage in the preterm infant. J Pediatr. 96:1980;1060-1063.
80. Hill A., Perlman J.M., Volpe J.J. Relationship of pneumothorax to the occurrence of intraventricular hemorrhage in the premature newborn. Pediatrics. 69:1982;144-149.
81. Bada H.S., Korones S.B., Perry E.H., Arheart K.L.et al. Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage. J Pediatr. 117:1990;607-614.
82. Perlman J.M., Volpe J.J. Are venous circulatory changes important in the pathogenesis of hemorrhagic and/or ischemic cerebral injury? Pediatrics. 80:1987;705-711.
83. Takashima S., Tanaka K. Microangiography and vascular permeability of the subependymal germinal matrix in the premature infant. Can J Neurol Sci. 5:1978;45-52.
84. Takashima S., Tanaka K. Microangiography and fibrinolytic activity in subependymal matrix of the premature brain. Brain Dev. 4:1972;222-228.
85. Conner E.S., Lorenzo A.V., Welch K., Dorval B. The role of intracranial hypotension in neonatal intraventricular hemorrhage. J Neurosurg. 58:1983;204.
86. Russell G.A.B., Jeffers G., Cook R.W.I. Plasma hypoxanthine: a marker for hypoxic-ischemic induced periventricular leukomalacia? Arch Dis Child. 67:1992;388-392.
87. Perlman J.M., Risser R. Relationship of uric acid concentrations and severe intraventricular hemorrhage/leukomalacia in the premature infant. J Pediatr. 132:1998;436-439.
88. Allen W.C., Vohr B., Makuch R.W. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. Arch Pediatr Adolesc Med. 151:1997;581-585.
89. Perlman J.M., Volpe J.J. Intraventricular hemorrhage in the extremely small premature infant. Am J Dis Child. 140:1986;1122-1124.
90. Shankaran S., Papile L.A., Wright L.L.et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. New Engl J Med. 337:1997;466-471.
91. Pomerance J.J., Teal J.G., Gogolok J.F., Brown S.et al. Maternally administered antenatal vitamin K: effect on neonatal prothrombin activity, partial prothrombin time and intraventricular hemorrhage. Obstet Gynecol. 70:1987;235-241.
92. Kazzi N., Llagan N.B., Liang K.C., Kassi G.M.et al. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. Pediatrics. 84:1989;1045-1050.
93. Garite T.J., Rumney P.J., Briggs G.C.et al. A randomized placebo controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation. Am J Obstet Gynecol. 166:1992;646-651.
94. Kari M.A., Hallman M., Gronen M., Teramo K.et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics. 93:1994;730-736.
95. Jobe A.H., Mitchell B.R., Gunkel J.H. Beneficial effects of combined use of prenatal steroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol. 168:1993;508-513.
96. Crowley P., Chalmers I., Keirse M.J.N.C. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from clinical trials. Br J Obstet Gynecol. 97:1990;11-25.
97. Shankaran S., Bauer C.R., Bain R. Prenatal and perinatal risk factors and protective factors for neonatal intracranial hemorrhage. Arch Pediatr Adolesc Med. 150:1996;491-497.
98. Maher J.E., Cliver S.P., Goldenberg R.L., Davis R.O.et al. March of Dimes Multicenter Study Group. The effect of glucocorticoid therapy in the very premature infant. Am J Obstet Gynecol. 170:1994;869-873.
99. Wright L.L., Homar J.D., Gunkel H. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birthweight infants. Am J Obstet Gynecol. 173:1995;263-269.
100. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in preterm infants. Pediatrics. 50:1972;515-525.
101. Garland J.S., Buck R., Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr. 126:1995;272-279.
102. Perlman J.M., Nissen P.D. Glial fibrillary acidic protein in RNA gene expression in human astroglial cells is modulated by dexamethasone (Abstract). Ann Neurol. 38:1995;495.
103. Perlman J.M., Risser R.C., Gee J.B. Pregnancy induced hypertension and reduced intraventricular hemorrhage in preterm infants. Pediatr Neurol. 17:1997;29-33.
104. Kuban K.C.K., Leviton A., Pagano M., Fenton T.et al. Maternal toxemia is associated with a reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol. 7:1992;70-76.
105. Leviton A., Pagano M., Kuban K.C.K., Krishnamoorthy K.S.et al. The epidemiology of germinal matrix hemorrhage during the first half of life. Dev Med Child Neurol. 33:1988;138-145.
106. Hadi H.A. Fetal cerebral maturation in hypertension disorder of pregnancy. Obstet Gynecol. 63:1984;214-219.
107. Gould J.B., Gluck L., Kulovich M.V. The relationship between accelerated pulmonary maturity and accelerated neurologic maturity in certain chronically stressed pregnancies. Am J Obstet Gynecol. 127:1977;181-186.
108. Nelson K.B., Grether J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics. 95:1995;263-269.
109. Leviton A, Paneth N, Susser MW, Lynn Reus M. et al. Magnesium receipt does not appear to reduce the risk of neonatal white matter damage. Pediatrics 1997;99:4.E2.
110. Paneth N, Jettan J, Pinto-Martron J, Susser M. Magnesium sulfate and risk of neonatal brain lesions and cerebral palsy in low birthweight infants. Pediatrics 1997;99:5.1-7.
111. Groome L.J., Goldenberg R.L., Cliver S.P., Davis R.O.et al. March of Dimes Multicenter Study Group: neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis. Am J Obstet Gynecol. 167:1992;873-879.
112. Atkinson M.W., Goldenberg R.L., Gaudier F.L., Cliver S.P.et al. Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birthweight infants. Am J Obstet Gynecol. 173:1995;299-304.
113. Anderson G.D., Bada H.S., Shaver B.M., Harvey C.J.et al. The effect of cesarean section on intraventricular hemorrhage in the premature infant. Am J Obstet Gynecol. 166:1992;1091-1101.
114. Low J.A., Galbraith R.S., Sauerbrei E.E., Muir D.W.et al. Maternal fetal and newborn complications associated with newborn intracranial hemorrhage. Am J Obstet Gynecol. 154:1986;345-351.
115. Strauss A., Kirz D., Mandalou H.D., Freeman R.K. Perinatal events and intraventricular/ependymal hemorrhage in the very low birthweight infant. Am J Obstet Gynecol. 151:1985;1022-1027.
116. Ment L.R., Oh W., Ehrenkrantz R., Philips A.G.S.et al. Antenatal steroids, delivery mode and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol. 172:1995;795-800.
117. Shankaran S., Bauer C.R., Bain R., Wright L.et al. Prenatal and perinatal risk and protective factors for neonatal intracranial hemorrhage. Arch Pediatr Adolesc Med. 150:1996;491-497.
118. Perlman J.M. Intraventricular hemorrhage. Pediatrics. 84:1989;913-914.
119. Perlman J.M., Thack B.T. Respiratory origin of fluctuations in arterial blood pressure in premature infants with respiratory distress syndrome. Pediatrics. 81:1988;399-403.
120. Perlman J.M., Goodman S., Kreusser K.L., Volpe J.J. Reduction of intraventricular hemorrhage by elimination of fluctuating cerebral blood flow velocity in preterm infants with respiratory distress syndrome. New Engl J Med. 312:1985;1253-1257.
121. Jobe A.H. Pulmonary surfactant therapy. New Engl J Med. 328:1993;861-868.
122. Donn S., Roloff D.W., Goldstein G.W. Prevention of intraventricular hemorrhage in preterm infants by phenobarbitone: a controlled trial. Lancet. ii:1981;215-217.
123. Bedard M.P., Shankaran S., Slovis T.L., Pantoya A.et al. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high risk infants. Pediatrics. 73:1984;435-439.
124. Kuban K.C., Leviton A., Krishnamoorthy K.S., Brown E.R.et al. Neonatal intracranial hemorrhage and phenobarbital. Pediatrics. 77:1986;443-450.
125. Sinha S., Davis J., Tonger N., Bogle S.et al. Vitamin E supplementation reduces frequency of periventricular hemorrhage in very preterm infants. Lancet. 11:1987;466-471.
126. Morgan M.E., Benson J.T., Cooke R.W. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birthweight babies. Lancet. 2:1981;830-831.
127. Benson J.T., Drayton M.R., Hayward C., Murphy J.F.et al. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants. Lancet. 2:1986;1297-1300.
128. Hanigan W.C., Kennedy G., Roemisch F., Anderson R.et al. Administration of indomethacin for prevention of periventricular intraventricular hemorrhage in high risk infants. Pediatrics. 112:1988;941-947.
129. Bandstra E.S., Montalvo B.M., Goldberg R.N., Pacheco I.et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics. 82:1988;533-542.
130. Bada H.S., Green R.S., Pourcyrous M., Leffler C.B.et al. Indomethacin reduces the risk of severe intraventricular hemorrhage. J Pediatr. 115:1989;631-637.
131. Ment L.R., Oh W., Ehrenkranz R.A., Philip A.G.S.et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 94:1994;543-550.
132. Amando T., Meyer J.S. Prostaglandin and human CBF control: effect of aspirin and indomethacin. J Cereb Blood Flow Metab. 1:1981;S402-404.
133. Pryds O., Griesen G., Johansen K.H. Indomethacin and cerebral blood flow in preterm infants treated for patent ductus arterious. J Pediatr. 147:1988;315-316.
134. Edwards A.D., Wyatt J.S., Richardson C., Potter A.et al. Effects of indomethacin on cerebral hemodynamics in very preterm infants. Lancet. 335:1990;491-495.